Contineum Therapeutics, Inc. (CTNM)
NASDAQ · Healthcare
Contineum Therapeutics, Inc. PS Ratio 2024–2026
Current and historical P/S ratio for Contineum Therapeutics, Inc. (CTNM): market cap divided by trailing twelve-month revenue. As of September 30, 2024 it is 9.85.
From: 09/30/2024To: 09/30/2024
Stock Price
TTM Revenue
PS Ratio
Contineum Therapeutics, Inc. PS Ratio — FAQ
Contineum Therapeutics, Inc. (CTNM) ps ratio over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CTNM's ps ratio history?
The chart and table above show Contineum Therapeutics, Inc.'s ps ratio by year and by quarter, including the growth rate.